Concepedia

External validation of the systemic immune-inflammation index as a prognostic factor in metastatic renal cell carcinoma and its implementation within the international metastatic renal cell carcinoma database consortium model

Paweł Chrom, Jakub Żołnierek, Lubomir Bodnar, Cezary Szczylik

International Journal of Clinical Oncology · 2019 · 32 citations · 22 references

References

22

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

Robert J. Motzer, Bernard Escudier, Saby George et al. · New England Journal of Medicine · 2015 · 5.9K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Robert J. Motzer, Nizar M. Tannir, Osvaldo Arén Frontera et al. · New England Journal of Medicine · 2018 · 4.6K citations · Full text

Medicine, Oncology, Pharmacotherapy +11

A note on quantifying follow-up in studies of failure time

M. Schemper, Terry L. Smith · Controlled Clinical Trials · 1996 · 2.5K citations

Public Health, Biostatistics, Survival Analysis +7

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

Michael Pencina, Ralph B. D’Agostino, Ewout W. Steyerberg · Statistics in Medicine · 2010 · 2.4K citations · Full text

Public Health, Biostatistics, Cardiology +17

Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan et al. · Journal of Clinical Oncology · 2009 · 2.1K citations · Full text

Medicine, Oncology, Pharmacology +17